Keri Vasquez Miloro, Author at Dysphagia Cafe

2 POSTS 0 COMMENTS

Keri Vasquez Miloro, MS, CAGS, CCC-SLP, BCS-S, has over 15 years of experience working with adults in acute and sub-acute facilities specializing in the treatment and management of dysphagia. She recently earned the Certificate of Advanced Graduate Study from Boston University where she was mentored by Dr. Susan Langmore and taught dysphagia courses at the graduate level. Keri has been actively involved in research with areas of interest in dysphagia rehabilitation and head neck cancer. Keri has presented at the Dysphagia Research Society’s annual conference, ASHA convention and an invited speaker at state-wide organizations. Keri is passionate about mentoring students and clinical fellows in which she has been the clinical instructor of over 25 students. Keri is an active member and Co-Vice President of Public Relations on the New Hampshire Speech Language Hearing Association. She is a board certified specialist in swallowing and swallowing disorders and recipient of 5 awards for continuing education recognized by ASHA.

Take my breath away: Expiratory muscle strength training to improve deglutition...

Keri Vasquez Miloro - October 1, 2016

Here comes the pitch: Effortful pitch glide in treatment of dysphagia

Keri Vasquez Miloro - July 9, 2014

Scroll for Important Safety Information

INDICATIONS AND USAGE:

VARIBAR ® THIN HONEY (barium sulfate) oral suspension, VARIBAR ® NECTAR (barium sulfate) oral suspension, and VARIBAR ® THIN LIQUID (barium sulfate) for oral suspension, are indicated for use in modified barium swallow examinations to evaluate the oral and pharyngeal function and morphology in adult and pediatric patients. VARIBAR ® HONEY (barium sulfate) oral suspension and VARIBAR ® PUDDING (barium sulfate) oral paste are indicated for use in modified barium swallow examinations to evaluate the oral and pharyngeal function and morphology in adult and pediatric patients 6 months of age and older.

IMPORTANT SAFETY INFORMATION:
For Oral Administration. This product should not be used in patients with known or suspected perforation of the GI tract, known obstruction of the GI tract, high risk of aspiration, or hypersensitivity to barium sulfate products. Rarely, severe allergic reactions of anaphylactoid nature have been reported following administration of barium sulfate contrast agents. Aspiration may occur during the modified barium swallow examination, monitor the patient for aspiration.

Please consult full Prescribing Information for VARIBAR products by clicking HERE.

You are encouraged to report negative side effects of prescription drugs to the FDA.
Visit FDA or call 1-800-FDA-1088.